Macpod 50 Oral Suspension contains Cefpodoxime Proxetil at a concentration of 50 mg per 5 ml and is a third-generation cephalosporin antibiotic indicated for the treatment of a variety of bacterial infections. It exhibits broad-spectrum activity against both Gram-positive and Gram-negative pathogens by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. Macpod 50 is commonly prescribed for respiratory tract infections such as bronchitis, pneumonia, and sinusitis, as well as urinary tract infections, skin and soft tissue infections, and otitis media. The oral suspension formulation facilitates ease of administration, particularly in pediatric and geriatric populations who may have difficulty swallowing tablets. Dosage should be determined based on the severity of infection, patient age, and renal function, with adherence to prescribed treatment duration to prevent resistance development. Common adverse effects include gastrointestinal disturbances such as diarrhea, nausea, and abdominal discomfort, while hypersensitivity reactions are rare but warrant immediate medical attention. Macpod 50 should be used cautiously in patients with a history of penicillin or cephalosporin allergy. It is contraindicated in individuals with known hypersensitivity to cefpodoxime or other beta-lactam antibiotics. As with all antibiotics, it is essential to complete the full course of therapy to ensure eradication of the infection and reduce the risk of resistance.